NCT05826509: SUrGery With or Without dARolutamide in High-risk and/or Locally Advanced Prostate Cancer
- State
- Under way
- Phase
- Phase 2
- People
- 240 planned
- Started
- 10 Aug 2023
- Primary completion
- Feb 2031
- Arms
- Experimental arm
- Results
- None posted
- 24 Apr 2023: Trial registered
- 10 Aug 2023: Trial started